jueves, 15 de octubre de 2026
How Far Away Are Oncologists From Diagnosing Ovarian Cancer Earlier? Zoe Cunniffe
https://www.medscape.com/viewarticle/how-far-away-are-oncologists-diagnosing-ovarian-cancer-2026a10012p4?src=
Two biotechnology companies are in the process of developing liquid biopsy tests that could detect ovarian cancer at early stages.
While these tools by Mercy BioAnalytics and DELFI Diagnostics are not yet FDA-approved, recent trials showed that they are much more sensitive than current screening methods for identifying stages I and II ovarian cancer.
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario